The Global Market for Pain Management Drugs and Devices

Published - Aug 2009| Analyst - Melissa Elder| Code - HLC026C
Market Research Report Single User License: $2750 Member Price: FREE

Report Highlights

  • The global market for pain management pharmaceuticals and devices amounted to $19.1 billion in 2008 and is expected to increase to $32.8 billion in 2013. The compound annual growth rate (CAGR) for the 5-year period is projected at 11.5%.
  • The pharmaceuticals segment dominated the market at $17.6 billion in 2008. That figure is expected to increase to $30.2 billion in 2013, for a CAGR of 11.5%.
  • The devices segment of the market generated $1.48 billion in sales in 2008 and is projected to increase to $2.5 billion in 2013, for a CAGR of 11.4%.


This BCC Research report, Pain Management Markets, provides an overview of products included in this market, and detailed analyses of markets and competitive environments. The study includes information about significant products, players, issues and trends, regulatory issues, and other information affecting the pain management industry.
This study will provide the reader with the knowledge to adequately view and assess pain management and the problems that the healthcare industry faces as well as provide insights into the market potentials. This covers a wide variety of treatments and products that many people worldwide rely on.
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the market for pain management. The geographical scope of this study is U.S. based. This study will address acute versus chronic pain, treatments, and regulatory issues facing healthcare workers. Also provided will is detailed information based on product categories, use of products, forecasts, and competitive analyses. Several significant trends continue to influence these markets. This report covers the following market trends:
  • Undertreatment issues
  • Professional issues
  • Managed care pain issues
  • Trends in new therapies and product pipelines
  • Generic participation
  • Pain research
  • Drug delivery
  • Patent expirations
  • Developments in breakthrough pain
  • New regulatory requirements
  • Demographic trends
  • Incidence and prevalence trends 
The information for this BCC report was obtained through primary and secondary data-collection methods. Primary methods included interviews with approximately 20 key executives, physicians, nurses, product managers, and other professionals involved in the pain treatment industry. Secondary methods included published literature in the area of pain management, investment reports, company literature, and various related journals.
Market data for this report pertains to the U.S. market and uses U.S. dollars at the manufacturers’ level. The base year of the report is 2008, with historical data provided for 2006 and 2007, and forecast data provided through 2013. Historical, base year and forecast data are provided for each market segment of the report. Growth rates are determined through a compilation of data, including past trends, future trends, demographics, incidence, mortality, products in research and development, and current product growth, etc. Competitor market share estimates are provided for each market segment for the 2008 base year.
Melissa Elder is an experienced healthcare market analyst, specializing in prescription and over-the-counter pharmaceuticals, medical devices, animal health products, and emerging healthcare technologies. Ms. Elder has more than 13 years of experience in the healthcare industry, specializing in market research for the past 10 years. This experience has given her substantial insight into pharmaceutical market analysis. Her work in the medical community, including emergency room medical training and healthcare information systems coordination, has enhanced her ability to provide insight into many healthcare markets. 
BCC Research offers an online information retrieval service. Its home page, at, enables readers to:
  • Examine the complete BCC Research catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC Research’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for its well-known conferences
  • Request additional information on any BCC research product
  • Take advantage of special offers.
This publication provides informative material of a professional nature. It does not constitute managerial, legal, or accounting advice, nor should it serve as a corporate policy guide or an endorsement of any given product or company. This information is intended to be as accurate as possible at the time it was written and was undertaken on a best-effort basis. 
The views expressed are those of the author and do not make any warranty, express or implied, for the accuracy, completeness, or usefulness of the information, or for the interpretation of data or its use by others. Projections involve risks and uncertainties that include but are not limited to technical risks associated with technology development, government regulatory approvals, and access to capital. The author assumes no responsibility for any losses or damages that may result from one’s reliance on this material.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Note: Reports are discounted or included with certain Memberships. See Membership Options.
Published - Jun-2007| Analyst - Alpita Shah| Code - HLC026B

Report Highlights

  • The global pain-management market is worth around $30.9 billion in 2007. It is forecasted to grow at a compound annual growth rate (CAGR) of 5.63% to reach $40.6 billion by the end of the forecast period, 2012.
  • The pharmaceuticals segment of the pain-management market is valued at $29 billion in 2007. It will be worth $38 billion by 2012 at a CAGR of 5.6%.
  • In 2007, market revenue from the medical devices segment is around $1.9 billion. This segment is predicted to grow at a CAGR of 6.5% to reach $2.6 billion by the end of 2012.
Published - Aug-2000| Analyst - Mary Anne Crandall| Code - HLC026A

Report Highlights

  • This report presents the forecast of the market for pain management through the year 2005. By 2005, it is anticipated that revenues will likely reach $32 billion, growing at an average annual rate of almost 12%.
  • Pain management pharmaceuticals currently hold the largest market revenue position, representing 97% and accounting for $16 billion of the total in 1999. Pharmaceuticals have long been the mainstay of pain management and it is anticipated that they will remain the largest market share throughout the forecast period.
  • Pain management devices account for 3%, representing $418.5 million in 1999. It is anticipated that the device segment will gain market revenue position due to technological advancements and a gradually declining cost increasing demand for current technologies


Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report